Study record
A Mighty Mitochondrial Microprotein: The Protective Role of MOTS-c in Acute Lung Injury
Kliment C · Am J Respir Cell Mol Biol · 2025
ReviewSeveralEvidence tier R
What this study reported
Commented, in an editorial on MOTS-c and acute lung injury, on a research report in the same journal. No abstract was available, so no measured outcomes could be extracted.
Limitations
Editorial with no abstract and no primary data; title-only annotation, so scope and claims could not be verified.
Study record
| Study model | Review |
|---|---|
| Substance studied | SeveralMore than one of these is central to the paper (common for reviews). |
| Species | Not reported |
| System studied | Editorial commentary on MOTS-c in acute lung injury |
| Population | Not reported |
| Design | Editorial comment |
| Sample size as reported | Not reported |
| Control group | Not reported |
| Route (data field only) | Not reported |
| Endpoints measured | not reported |
| Pathways measured | Not reported |
| Research areas | Lung · Mitochondrial biology |
| Evidence tier | R — Review (context, not evidence) |
| Publication types | Editorial, Comment |
Appraisal
Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.
- Relevance to MOTS-c
- Direct
- Model applicability
- n/a
- Sample size
- n/a
- Controls
- n/a
- Outcome validity
- n/a
- Support for its own conclusion
- n/a
Provenance
- Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
- Annotated from the title only, because no abstract is indexed.
- Editorial review: approved (2026-11-11).
- Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.